U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07049978) titled 'Long-term Effect of Dupilumab in N-ERD' on June 25.
Brief Summary: This prospective observational study investigates the long-term effects of Dupilumab in patients with NSAID-exacerbated respiratory disease (N-ERD). The study assesses changes in ASA tolerance, clinical parameters, inflammatory biomarkers, quality of life, and nasal microbiome during ongoing treatment with Dupilumab. All participants are receiving Dupilumab as part of standard clinical care.
Study Start Date: July 01
Study Type: OBSERVATIONAL
Condition:
NSAID-Induced Asthma
NSAIDs Hypersensitivity
Chronic Rhinosinusitis (CRS)
Asthma Bronchiale
Nasal Polyposis
Int...